CDH1, GART, GTSE1, NEK2 and hsa-miR-496, hsa-miR-214, hsa-miR-15b were found to be correlated with survival and may be potential molecular biomarkers for predicting the clinical risk of BE patient progressing to EAC. The gene discussed is GTSE1; the disease is Barrett esophagus.